See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.
Licensing for formulation of a malaria antigen for use as a human malaria vaccine
eagle-i ID
http://hawaii.eagle-i.net/i/00000130-2884-67df-cec9-714480000000
Resource Type
Properties
-
-
Resource Description
-
"This technology deals with compositions of the baculovirus MSP1 p42 polypeptide and adjuvants which comprise immunogenic formulations in non-human primates. Studies have identified two pharmaceutically-acceptable adjuvants capable of inducing a potent humoral and cellular immune responses in Aotus and conferring partial protection against P. falciparum infection."
-
-
Contact
-
Taylor, Lee
-
-
Service Provided by
-
Office of Technology Transfer and Economic Development (OTTED)
-
-
Website(s)
-
http://www.otted.hawaii.edu/technology/00220/formulation-malaria-antigen-clinically-acceptably-adjuvants-use-human-malaria-vacci
